$1.29 Billion is the total value of Novo Holdings A/S's 41 reported holdings in Q2 2023. The portfolio turnover from Q1 2023 to Q2 2023 was 17.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ASML | Sell | ASML HOLDING N V | $143,326,560 | -7.2% | 197,760 | -12.8% | 11.08% | +8.7% |
| CRM | Sell | SALESFORCE.COM, INC. | $112,073,430 | -3.0% | 530,500 | -8.3% | 8.66% | +13.6% |
| LANZATECH GLOBAL INC | $108,015,391 | +76.0% | 15,814,845 | 0.0% | 8.35% | +106.1% | ||
| CORT | CORCEPT THERAPEUTICS INC | $75,155,338 | +2.7% | 3,377,768 | 0.0% | 5.81% | +20.3% | |
| TSM | TAIWAN SEMICONDUCTOR MFG LTDsponsored ads | $71,731,918 | +8.5% | 710,780 | 0.0% | 5.54% | +27.1% | |
| CABO | CABLE ONE INC | $61,833,199 | -6.4% | 94,103 | 0.0% | 4.78% | +9.6% | |
| Sell | DISC MEDICINE, INC. | $48,430,293 | -2.4% | 1,090,772 | -53.4% | 3.74% | +14.3% | |
| EWTX | EDGEWISE THERAPEUTICS INC | $47,055,698 | +16.2% | 6,071,703 | 0.0% | 3.64% | +36.1% | |
| MIRM | MIRUM PHARMACEUTICALS INC | $43,570,073 | +7.7% | 1,684,193 | 0.0% | 3.37% | +26.2% | |
| AAPL | Sell | APPLE INC | $42,956,596 | -11.8% | 221,460 | -25.0% | 3.32% | +3.3% |
| PCVX | Buy | VAXCYTE INC | $42,199,300 | +51.1% | 845,000 | +13.4% | 3.26% | +77.0% |
| BABA | ALIBABA GROUP HLDG LTDsponsored ads | $41,743,930 | -18.4% | 500,827 | 0.0% | 3.23% | -4.4% | |
| BMRN | Buy | BIOMARIN PHARMACEUTICAL INC | $34,672,000 | -2.9% | 400,000 | +8.9% | 2.68% | +13.7% |
| Sell | ARCELLX, INC. | $31,620,000 | -16.2% | 1,000,000 | -18.4% | 2.44% | -1.9% | |
| SGEN | Buy | SEAGEN INC. | $30,790,906 | +12.7% | 159,986 | +18.5% | 2.38% | +31.9% |
| BPMC | BLUEPRINT MEDICINES CORP | $28,364,413 | +40.5% | 448,804 | 0.0% | 2.19% | +64.6% | |
| INSM | INSMED INC | $28,259,314 | +23.8% | 1,339,304 | 0.0% | 2.18% | +44.9% | |
| FOLD | AMICUS THERAPEUTICS INC | $26,324,504 | +13.3% | 2,095,900 | 0.0% | 2.03% | +32.6% | |
| ALNY | ALNYLAM PHARMACEUTICALS INC | $22,485,667 | -5.2% | 118,383 | 0.0% | 1.74% | +11.0% | |
| CBAY | New | CYMABAY THERAPEUTICS INC | $21,900,000 | – | 2,000,000 | +100.0% | 1.69% | – |
| RPHM | Sell | RENEO PHARMACEUTICALS INC | $21,847,273 | +6.5% | 3,330,377 | -2.9% | 1.69% | +24.8% |
| BAM | Sell | BROOKFIELD ASSET MGMT INCcl a ltd vt sh | $20,465,764 | -75.1% | 627,207 | -75.0% | 1.58% | -70.8% |
| PHVS | PHARVARIS N V | $20,125,981 | +87.8% | 1,329,325 | 0.0% | 1.56% | +119.9% | |
| CRNX | CRINETICS PHARMACEUTICALS IN | $19,822,000 | +12.2% | 1,100,000 | 0.0% | 1.53% | +31.4% | |
| RCKT | ROCKET PHARMACEUTICALS INC | $18,280,400 | +16.0% | 920,000 | 0.0% | 1.41% | +35.9% | |
| FDMT | Buy | 4D MOLECULAR THERAPEUTICS IN | $18,070,000 | +50.2% | 1,000,000 | +42.9% | 1.40% | +75.8% |
| SPRB | SPRUCE BIOSCIENCES INC | $14,453,022 | -2.7% | 6,722,336 | 0.0% | 1.12% | +14.0% | |
| Sell | RALLYBIO CORP | $12,384,074 | -4.5% | 2,187,999 | -3.6% | 0.96% | +11.9% | |
| SILK | Buy | SILK RD MED INC | $10,847,891 | +0.6% | 333,884 | +21.2% | 0.84% | +17.9% |
| INSP | Sell | INSPIRE MED SYS INC | $10,550,800 | -24.9% | 32,500 | -45.8% | 0.82% | -12.1% |
| CYT | Sell | CYTEIR THERAPEUTICS INC | $9,522,854 | -91.6% | 3,662,636 | -7.0% | 0.74% | -90.1% |
| VERV | Sell | VERVE THERAPEUTICS INC | $9,375,000 | -45.8% | 500,000 | -58.3% | 0.72% | -36.6% |
| TMCI | Sell | TREACE MED CONCEPTS INC | $9,208,800 | -32.3% | 360,000 | -33.3% | 0.71% | -20.6% |
| ABCL | ABCELLERA BIOLOGICS INC | $7,279,871 | -14.3% | 1,126,915 | 0.0% | 0.56% | +0.4% | |
| GRTX | Sell | GALERA THERAPEUTICS INC | $6,552,000 | +4.1% | 2,100,000 | -14.6% | 0.51% | +21.9% |
| IO BIOTECH INC | $6,408,357 | +4.3% | 3,277,932 | 0.0% | 0.50% | +21.9% | ||
| GLTO | GALECTO INC | $6,294,433 | +26.6% | 2,497,791 | 0.0% | 0.49% | +48.2% | |
| LVTX | Sell | LAVA THERAPEUTICS NV | $4,872,000 | -4.4% | 2,400,000 | -21.8% | 0.38% | +11.9% |
| KNTE | KINNATE BIOPHARMA INC | $2,471,592 | -51.5% | 815,707 | 0.0% | 0.19% | -43.2% | |
| MQ | MARQETA INC | $2,150,387 | +6.6% | 441,558 | 0.0% | 0.17% | +24.8% | |
| SPRO | SPERO THERAPEUTICS INC | $679,908 | 0.0% | 468,902 | 0.0% | 0.05% | +17.8% | |
| KZR | Exit | KEZAR LIFE SCIENCES INC | $0 | – | -465,604 | -100.0% | -0.10% | – |
| LUNG | Exit | PULMONX CORP | $0 | – | -510,555 | -100.0% | -0.38% | – |
| NARI | Exit | INARI MED INC | $0 | – | -180,000 | -100.0% | -0.73% | – |
| BLU | Exit | BELLUS HEALTH INC. | $0 | – | -2,137,975 | -100.0% | -1.02% | – |
| Exit | DICE THERAPEUTICS, INC. | $0 | – | -536,100 | -100.0% | -1.10% | – | |
| VECT | Exit | VECTIVBIO HLDG AG | $0 | – | -3,610,461 | -100.0% | -2.03% | – |
| CTLT | Exit | CATALENT INC | $0 | – | -832,878 | -100.0% | -3.61% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-08-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| VANGUARD INDEX FDS | 41 | Q3 2022 | 64.7% |
| INOGEN INC | 34 | Q2 2022 | 68.8% |
| VANGUARD INTL EQUITY INDEX F | 29 | Q4 2016 | 37.6% |
| AMICUS THERAPEUTICS INC | 22 | Q3 2023 | 4.1% |
| AKEBIA THERAPEUTICS INC | 21 | Q3 2020 | 4.8% |
| VERONA PHARMA PLC | 21 | Q2 2022 | 1.9% |
| CORVUS PHARMACEUTICALS INC | 20 | Q4 2020 | 7.1% |
| INSPIRE MED SYS INC | 20 | Q3 2023 | 1.8% |
| CABLE ONE INC | 19 | Q3 2023 | 9.7% |
| FLEXION THERAPEUTICS INC | 19 | Q3 2021 | 4.7% |
View Novo Holdings A/S's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Cyteir Therapeutics, Inc. | August 03, 2023 | 1,547,136 | 4.4% |
| Disc Medicine, Inc. | June 28, 2023 | 1,090,772 | 4.8% |
| Galera Therapeutics, Inc. | June 28, 2023 | 2,100,000 | 4.9% |
| VectivBio Holding AGSold out | May 26, 2023 | 0 | 0.0% |
| LanzaTech Global, Inc. | February 17, 2023 | 15,814,845 | 8.1% |
| Bolt Biotherapeutics, Inc.Sold out | January 04, 2023 | 0 | 0.0% |
| Arcellx, Inc. | December 12, 2022 | 1,750,000 | 4.0% |
| MINERVA SURGICAL INC | November 03, 2022 | 1,322,473 | 4.5% |
| Milestone Pharmaceuticals Inc. | October 24, 2022 | 1,378,538 | 4.6% |
| Galecto, Inc. | September 30, 2022 | 2,497,791 | 9.8% |
View Novo Holdings A/S's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13D/A | 2024-03-28 |
| 4 | 2024-03-25 |
| SC 13D/A | 2024-03-25 |
| 4 | 2024-03-20 |
| SC 13D/A | 2024-03-20 |
| 144 | 2024-03-18 |
| 4 | 2024-03-18 |
| SC 13D/A | 2024-03-18 |
| 144 | 2024-03-14 |
| SC 13D/A | 2024-03-07 |
View Novo Holdings A/S's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.